Oxidative Stress in Cystic Fibrosis: Does It Occur and Does It Matter?

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 491-513

  Van Der Vliet, Albert ^a   Eiserich, Jason P ^a   Marelich, Gregory P ^a,b   Halliwell, Barry ^a,c   Cross, Carroll Edward ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001052548     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60996-5     Document Type: Article

References (155)

1. Abe K., Pan L.-H., Watanabe M., Kato T., and Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199 (1995) 152-154
2. Adnot S., Raffestin B., and Eddahibi S. NO in the lung. Resp. Physiol. 101 (1995) 109-120
3. Aruoma O.I., and Halliwell B. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron: Are lactoferrin and transferrin promoters of hydroxyl-radical generation?. Biochem. J. 241 (1987) 273-278
4. Aruoma O.I., Halliwell B., Hoey B.M., and Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad. Biol. Med. 6 (1989) 593-597
5. Asano K., Chee C.B.E., Gaston B., Lilly C.M., Gerard C., Drazen J.M., and Stamler J.S. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10089-10093
6. Bartlett D., Church D.F., Bounds P.L., and Koppenol W.H. The kinetics of the oxidation of L-ascorbic acid by peroxynitrite. Free Rad. Biol. Med. 18 (1995) 85-92
7. Beckman J.S., Ischiropoulos H., Zhu L., Van Der Woerd M., Smith C., Chen J., Harrison J., Martin J.C., and Tsai M. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298 (1992) 438-445
8. Beckman J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., and White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biochem. Hoppe-Seyler 375 (1994) 81-88
9. Belvisi M., Barnes P.J., Larkin S., Yacoub M., Tadjkarimi S., Williams T.J., and Mitchell J.A. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur. J. Pharmacol. 283 (1995) 255-258
10. Bilton D., Maddison J., Webb A.K., Seabra L., Jones M., and Braganza J.M. Cystic fibrosis, breath pentane, and lipid peroxidation. Lancet 338 (1991) 1420
11. Bitter P. Proteases and antiproteases in cystic fibrosis: Pathogenetic considerations and therapeutic strategies. Resp. 62 Suppl. 1 (1995) 25-28
12. Birrer P., Mcelvaney N.G., Rudeberg A., Wirz Sommer C., Liechti-Gallati S., Kraemer R., Hubbard R., and Crystal R.G. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150 (1994) 207-213
13. Boat T.F., Welsh M.J., and Beaudet A.L. Cystic fibrosis. In: Scriver C.R., et al. (Ed). "The Metabolic Basis of Inherited Diseases". 6th Ed. (1989), McGraw-Hill, New York 2649-2680
14. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., and Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir Crit. Care Med. 152 (1995) 2111-2118
15. Boucher R.C. Human airway ion transport. Part one. Am. J. Respir. Crit. Care Med. 150 (1994) 271-281
16. Boucher R.C. Human airway ion transport. Part two. Am. J. Respir. Crit. Care Med. 150 (1994) 581-593
17. Britigan B.E., and Edeker B.L. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J. Clin. Invest. 88 (1991) 1092-1102
18. Britigan B.E., Rasmussen G.T., and Cox C.D. Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury. Am. J. Physiol. 266 (1994) L192-L198
19. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 9 (1995) 1551-1558
20. Britton M., Fong C., Wickens D., and Yudkin J. Diet as a source of phospholipid esterified 9,11-octadecadienoic acid in humans. Clin. Sci. 83 (1992) 97-101
21. Brown R.K., and Kelly F.J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr. Res. 36 (1994) 487-493
22. Brown R.K., and Kelly F.J. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49 (1994) 738-742
23. Brown R.K., Mcburney A., Lunec J., and Kelly F.J. Oxidative damage to DNA in patients with cystic fibrosis. Free Rad. Bio. Med. 18 (1995) 801-806
24. Bruce M.C., Poncz L., Klinger J.D., Stern R.C., Tomashefski Jr. J.F., and Dearborn D.G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 132 (1985) 529-535
25. Cantin A., and Woods D.E. Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J. Clin. Invest. 91 (1993) 38-45
26. Cameras M.C., Pargament G.A., Catz S.D., Poderoso J.J., and Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 341 (1994) 65-68
27. Casavola V., Turner R.J., Guay-Broder C., Jacobson K.A., Eidelman O., and Pollard H.B. CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells. Am. J. Physiol. 38 (1995) C226-C233
28. Castillo R., Landon C., Eckhardt K., Morris V., Levander O., and Lewiston N. Selenium and vitamin E status in cystic fibrosis. J. Pediatr. 99 (1981) 583-585
29. Cattell V., and Jansen A. Inducible nitric oxide synthase in inflammation. Histochem. J. 27 (1995) 777-784
30. Cross C.E., Halliwell B., and Allen A. Antioxidant protection: A function of tracheo-bronchial and gastrointestinal mucus. Lancet 1 (1984) 1328-1330
31. Cross C.E., Van Der Vliet A., O'Neill C.A., and Eiserich J.P. Free radicals and antioxidants: Reactive oxygen species and the lung. Lancet 344 (1994) 930-933
32. Cross C.E., Van Der Vliet A., O'Neill C.A., Louie S., and Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ. Health Perspect. 102 Suppl. 10 (1994) 185-192
33. Crystal R.G. Oxidants and respiratory tract epithelial injury: Pathogenesis and strategies for therapeutic intervention. Am. J. Med. 91 Suppl. 3C (1991) 39S-44S
34. Crystal R.G., Mcelvaney N.G., Rosenfeld M.A., Chu C.-S., Mastrangeli A., Hay J.G., Brody S.L., Jaffe H.A., Eissa N.T., and Danel C. Administration of an adenovirus containing the human CFTR CDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 8 (1994) 42-51
35. Curiel D.T., Pilewski J.M., and Albelda S.M. Minireview: Gene approaches for inherited and acquired lung diseases. Am. J. Respir. Cell Mol. Biol. 14 (1996) 1-8
36. Dabbagh A.J., and Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J. Clin. Invest. 96 (1995) 1958-1966
37. Danel C., Erzurum S.C., Mcelvaney N.G., and Crystal R.G. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am. J. Respir. Crit. Care Med. 153 (1996) 362-368
38. Darley-Usmar V., Wiseman H., and Halliwell B. Nitric oxide and oxygen radicals: A question of balance. FEBS Lett. 369 (1995) 131-135
39. Davis W.B., and Pacht E.R. Extracellular antioxidant defenses. In: Crystal R.G., West J.B., Barnes P.J., Cherrniack N.S., and Weibel E.R. (Eds). "The Lungs: Scientific Foundations" (1991), Raven Press, New York 1821-1826
40. Domigan N.M., Charlton T.S., Duncan M.W., Winterbourne C.C., and Kettle A.J. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J. Biol. Chem. 270 (1995) 16542-16548
41. Dorin J.R. Development of mouse models for cystic fibrosis. J. Inherit. Metab. Dis. 18 (1995) 495-500
42. Drumm M.L., Pope H.A., Cliff W.H., Rommens J.M., Marvin S.A., Tsui L.C., Collins F.S., Frizzell R.A., and Wilson J.M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62 (1990) 1227-1233
43. Elborn J.S., Cordon S.M., Western P.J., Macdonald I.A., and Shale D.J. Tumor necrosis factor-α, resting energy expenditure and cachexia in cystic fibrosis. Clin. Sci. 85 (1993) 563-568
44. Folkes L.K., Candeias L.P., and Wardman P. Kinetics and mechanisms of hypochlorous acid reactions. Arch. Biochem. Biophys. 323 (1995) 120-126
45. Francoeur C., and Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 195 (1995) 587-598
46. Freeman B.A., Gutierrez H., and Rubbo H. Nitric oxide: A central regulatory species in pulmonary oxidant reactions. Am. J. Physiol. 268 (1995) L697-L698
47. Gaboury J., Woodman R.C., Granger D.N., Reinhardt P., and Kubes P. Nitric oxide prevents leukocyte adherence: Role of superoxide. Am. J. Physiol. 265 (1993) H862-H867
48. Gadsby D.C., and Nairn A.C. Regulation of CFTR channel gating. Trends Biochem. Sci. 19 (1994) 513-518
49. Grisham M.B., Von Ritter C., Smith B.F., Lamont J.T., and Granger D.N. Interaction between oxygen radicals and gastric mucin. Am. J. Physiol. 253 (1987) G93-G96
50. Gum J.R. Human mucin glycoproteins: Varied structures predict diverse properties and specific functions. Biochem. Soc. Trans. 23 (1996) 795-799
51. Guo F.H., De Raeve H.R., Rice T.W., Stuehr D.J., Thunnissen F.B.J.M., and Erzurum S.C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. U.S.A. 99 (1995) 7809-7813
52. Gustafsson L.E., Leone A.M., Persson M.G., Wiklund N.P., and Moncada S. Endogenous nitric oxide is present in exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181 (1991) 852-857
53. Gutierrez H.H., Pitt B.R., Schwarz M., Watkins S.C., Lowenstein C., Caniggia I., Chumley P., and Freeman B.A. Pulmonary alveolar epithelial inducible NO synthase gene expression: Regulation by inflammatory mediators. Am. J. Physiol. 268 (1995) L501-L508
54. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41 (1995) 1819-1828
55. Haas B., Kraut J., Marks J., Zanker S.C., and Castignetti D. Siderophore presence in sputa of cystic fibrosis patients. Infect. Immun. 59 (1991) 3997-4000
56. Haddad I.Y., Crow J.P., Hu P., Ye Y., Beckman J., and Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 267 (1994) L242-L249
57. Haddad I.Y., Ischiropoulos J., Holm B.A., Beckman J.S., Baker J.R., and Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265 (1993) L555-L564
58. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94 (1994) 2407-2413
59. Halliwell B., and Chirico S. Lipid peroxidation: Its mechanism, measurement and significance. Am. J. Clin. Nutr. 57 Suppl. (1993) 715S-725S
60. Halliwell B., Cross C.E., and Gutteridge J.M.C. Free radicals, antioxidants, and human disease: Where are we now?. J. Lab. Clin. Med. 119 (1992) 598-620
61. Halliwell B., and Gutteridge J.M.C. "Free Radicals in Biology and Medicine". 2nd Ed. (1989), Clarendon Press, Oxford
62. Halliwell B., and Gutteridge J.M.C. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280 (1990) 1-8
63. Heinecke J.W., Li W., Francis G.A., and Goldstein J.A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91 (1993) 2866-2872
64. Hogg J.C. Neutrophil kinetics in lung injury. Physiol. Rev. 67 (1987) 1249-1295
65. Homnick D.N., Cox J.H., Deloof M.J.H., and Ringer T.V. Carotenoid levels in normal children and in children with cystic fibrosis. J. Pediatr. 122 (1993) 703-707
66. Hu M.L., Louie S., Cross C.E., Motchnik P., and Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 121 (1992) 257-262
67. Huie R.E., and Padmaja S. The reaction of NO with superoxide. Free Rad. Res. Commun. 18 (1993) 1995-1999
68. Hunninghake G.W., and Crystal R.G. Cigarette smoking and lung destruction: Accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis. 128 (1983) 833-838
69. Huston P., Espenson J.H., and Bakac A. Reactions of thiyl radicals with transition-metal complexes. J. Am. Chem. Soc. 114 (1992) 9510-9516
70. Imundo L., Barasch J., Prince A., and Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natf. Acad. Sci. U.S.A. 92 (1995) 3019-3023
71. Ischiropoulos H., and Al-Mehdi A.B. Reactive species in ischemic rat lung injury: Contribution of peroxynitrite. Am. J. Physiol. 269 (1995) L158-L164
72. Ischiropoulos H., Zhu L., and Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298 (1992) 446-451
73. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., and Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298 (1992) 431-437
74. James D.R., Alfaham M., and Goodchild M.C. Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis. Clin. Chim. Acta 204 (1991) 279-290
75. Kaur H., and Halliwell B. Evidence for nitric oxide-mediative damage in chronic inflammation: Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350 (1994) 9-12
76. Kettle A.J. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett. 379 (1996) 103-106
77. Kharitonov S.A., Wells A.U., O'Connor B.J., Cole P.J., Hansell D.M., Logan-Sinclair R.B., and Barnes P.J. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 151 (1995) 1889-1893
78. Kharitonov S.A., Yates D., and Barnes P.J. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 8 (1995) 295-297
79. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., and Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
80. Kimberly B., Nejadnik B., Giraud G.D., and Holden W.E. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am. J. Respir. Crit. Care Med. 153 (1996) 829-836
81. Kneepkens C.M.F., Ferreira C., Lepage G., and Roy C.C. Hydrocarbon breath test in cystic fibrosis: Evidence for increased lipid peroxidation. J. Pediatr. Gastroenterol. Nutr. 15 (1992) 344 [Abstract]
82. Kobzik L., Bredt D., Lowenstein C., Snyder S.H., Drazen J.M., Sugarbaker D., and Stamler J.S. Nitric oxide synthase in human and rat lung. Am. J. Respir. Cell Mol. Biol. 9 (1993) 371-377
83. Kohlmuller D., and Kochen W. Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Anal. Biochem. 210 (1993) 268-276
84. Konstan M.W., Hilliard K.A., Norvell T.M., and Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150 (1994) 448-454
85. Kooy N.W., and Royall J.A. Agonist-induced peroxynitrite production from endothelial cells. Arch. Biochem. Biophys. 310 (1994) 352-359
86. Kooy N.W., Royall J.A., Ye Y.Z., Kelly D.R., and Beckman J.S. Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med. 151 (1995) 1250-1254
87. Korge P., and Campbell K.B. The effect of changes in iron redox state on the activity of enzymes sensitive to medication of SH groups. Arch. Biochem. Biophys. 304 (1993) 420-428
88. Krinsky N.I. Annu. Rev. Nutr. 13 (1993) 561-587 (and references cited therein).
89. Krinsky N.I., and Sies H. The present status of antioxidant vitamins and beta-carotene. Am. J. Clin. Nutr. 62 Suppl. (1995) 1299S-1300S
90. Kurose I., Wolf R., Grisham M.B., Ty A., Specian R.D., and Granger D.N. Microvascular responses to inhibition of nitric oxide production: Role of active oxidants. Circ. Res. 76 (1995) 30-39
91. Lepage G., Champagne J., Ronco N., Lamarre A., Osberg I., Sokol R.J., and Roy C.C. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am. J. Clin. Nutr. 64 (1996) 87-93
92. Litwin C.M., and Caldenvood S.B. Role of iron in regulation of virulence genes. Clin. Microbiol. Rev. 6 (1993) 137-149
93. Mangione S., Patel D.D., Levin B.R., and Fiel S.B. Erythrocytic glutathione in cystic fibrosis. Chest 105 (1994) 1470-1473
94. Marelich G.P., and Cross C.E. Cystic fibrosis in adults: From researcher to practitioner. West. J. Med. 164 (1996) 321-334
95. Marquez L.A., and Dunford H.B. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. J. Biol. Chem. 270 (1995) 30434-30440
96. Masson P.L., Heremans J.F., Prignot J.J., and Wauters G. Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial glands. Thorax 21 (1977) 538-544
97. Matkovics B., Gyurkovits K., LÁSzlÓ A., and SzabÓ L. Altered peroxide metabolism in erythrocytes from children with cystic fibrosis. Clin. Chim. Acta 125 (1982) 59-62
98. Mcelvaney N.G., Hubbard R.C., Birrer P., et al. Aerosol α-I-antitrypsin treatment for cystic fibrosis. Lancet 337 (1991) 392-394
99. Mergey M., Lemnaouar M., Veissiere D., Perricaudet M., Gruenert D.C., Picard J., Capeau J., Brahimi-Horn M.-C., and Paul A. CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. Am. J. Physiol. 269 (1995) L555-L864
100. Meyer K., Brown R., and Zimmerman J. Myeloperoxidase and dityrosine in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 151 (1995) A248
101. Miles A.M., Owens M.W., Milligan S., Johnson G.G., Fields J.Z., Ing T.S., Kottapalli V., Keshavarzian A., and Grisham M.B. Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J. Leukocyte Biol. 58 (1995) 616-622
102. Mohammed J.R., Mohammed B.S., Pawluk L.J., Bucci D.M., Baker N.R., and Davis W.B. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J. Lab. Clin. Med. 112 (1988) 711-720
103. Mulligan M.S., Hevel J.M., Marletta M.A., and Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Natl. Acad. Sci. U.S.A. 88 (1991) 6338-6342
104. Munday R. Toxicity of thiols and disulphides: Involvement of free-radical species. Free Rad. Biol. Med. 7 (1989) 659-673
105. Nagaki M., Shimura S., Irokawa T., Saski T., and Shirato K. Nitric oxide regulation of glycoconjugate secretion from feline and human airways in vitro. Respir. Physiol. 102 (1995) 79-88
106. Niggemann B., Stiller T., Magdorf K., and Wahn U. Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection. Mediat. Inflamm. 4 (1995) 282-288
107. O'Connor C.M., Gaffney K., Keane J., Southey A., Byrne N., O'Mahoney S., and Fitzgerald M.X. α1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am. Rev. Respir. Dis. 148 (1993) 1665-1670
108. Pacht E.R., Timerman A.P., Lykens M.G., and Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100 (1991) 1397-1403
109. Peden D.B., Swiersz M., Ohkubo K., and Hahn B. Nasal secretion of the ozone scavenger uric acid. Am. Rev. Respir. Dis. 148 (1993) 455-461
110. Persson C.G.A., Erjefalt I., Alkner U., Baumgarten C., Greiff L., Gustafsson B., Luts A., Pipkorn U., Sundler F., Svensson C., and Wollmer P. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21 (1991) 17-24
111. Pfeffer K.D., Huecksteadt T.P., and Hoidal J.R. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am. J. Respir. Cell Mol. Biol. 9 (1993) 511-519
112. Pier G.B., Grout M., Zaidi T.S., Olsen J.C., Johnson L.G., Yankaskas J.R., and Goldberg J.B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271 (1996) 64-67
113. Portal B., Richard M.J., Ducros V., Aguilaniu B., Brunel F., Faure H., Gout J.P., Bost M., and Favier A. Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients. Clin. Chem. 39 (1993) 1023-1028
114. Portal B.C., Richard M.-J., Faure H.S., Hadjian A.J., and Favier A.E. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am. J. Clin. Nutr. 61 (1995) 843-847
115. Pryor W.A. Can vitamin E protect us against the pathological effects of ozone in smog?. Am. J. Clin. Nutr. 53 (1991) 702-722
116. Pryor W.A., Jin X., and Squadrito G.L. One- and two-electron oxidations of methionine by peroxynitrite. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11173-11177
117. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
118. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 (1991) 481-487
119. Ramsey B.W., Farrell P.M., Pencharz P., and Consensus Committee. Nutritional assessment and management in cystic fibrosis: A consensus report. Am. J. Clin. Nutr. 55 (1992) 108-116
120. Regelmann W.E., Skubitz K.M., and Herron J.M. Increased monocyte oxidase activity in cystic fibrosis heterozygotes and homozygotes. Am. J. Respir. Cell Mol. Biol. 5 (1991) 27-33
121. Robbins R.A., Springall D.R., Warren J.B., Kwon O.J., Buttery L.D.K., Wilson A.J., Adcock I.M., Riveros-Moreno V., Moncada S., Polak J., and Barnes P.J. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198 (1994) 835-843
122. Rosenfeld M.A., and Collins F.S. Gene therapy for cystic fibrosis. Chest 109 (1996) 241-252
123. Ross A.C. Cellular metabolism and activation of retinoids: Roles of cellular retinoid-binding proteins. FASEB J. 7 (1993) 317-327
124. Roum J.H., Buhl R., Mcelvaney N.G., Borok Z., and Crystal R.G. Systemic deficiency of glutathione in cystic fibrosis. J. Appl. Physiol. 75 (1993) 2419-2424
125. Rowe P.M. Beta-carotene takes a collective beating. Lancet 347 (1996) 249
126. Rubbo H., Parthasarathy S., Barnes S., Kirk M., Kalyanaraman B., and Freeman B.A. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipo-protein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch. Biochem. Biophys. 324 (1995) 15-25
127. Salh B., Webb K., Guyan P.M., Day J.P., Wickens D., Griffin J., Braganza J.M., and Dormandy T.L. Aberrant free radical activity in cystic fibrosis. Clin. Chim. Acta 181 (1989) 65-74
128. Salman-Tabcheh S., Guerin M.-C., and Torreilles J. Nitration of tyrosyl-residues from extra- and intracellular proteins in human whole blood. Free Rad. Biol. Med. 19 (1995) 695-698
129. Schedin U., Frostell C., and Gustafsson L.E. Nitric oxide occurs in high concentrations in monkey upper airways. Acta Physiol. Scand. 155 (1995) 473-474
130. Schwiebert E.M., Egan M.E., Hwang T.H., Fulmer S.B., Allen S.S., Cutting G.R., and Guggino W.B. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81 (1995) 1063-1073
131. Simpson J.A., Smith S.E., and Dean R.T. AIginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Biochem. Mol. Biol. Inter. 30 (1993) 1021-1034
132. Slade R., Crissman K., Norwood J., and Hatch G. Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. Exp. Lung Res. 19 (1993) 469-484
133. Sparrow C.P., and Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34 (1993) 1219-1228
134. Stewart T.E., Valenza F., Ribeiro S.P., Wener A.D., Volgyesi G., Mullen J.B.M., and Slutsky A.S. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am. J. Respir. Crit. Care Med. 151 (1995) 713-718
135. Stone P.J., Konstan M.W., Berger M., Dorkin H.L., Franzblau C., and Snider G.L. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 152 (1995) 157-162
136. Tsuchihashi H., Kigoshi M., Iwatsuki M., and Niki E. Action of β-carotene as an antioxidant against lipid peroxidation. Arch. Biochem. Biophys. 323 (1995) 137-147
137. Tsui L.-C. The cystic fibrosis transmembrane conductance regulator gene. Am. J. Respir. Crit. Care Med. 151 (1995) S47-S53
138. Tsui L., and Buchwald M. Biochemical and molecular genetics of cystic fibrosis. In: Harris H., and Hirschhorn K. (Eds). "Advances in Human Genetics" 20 (1991), Plenum, New York 153-266
139. Van Antwerpen V.L., Theron A.J., Richards G.A., et al. Plasma levels of beta-carotene are inversely correlated with circulating neutrophil counts in young male cigarette smokers. Inflammation 19 (1995) 405-414
140. Van Der Vliet A., Eiserich J.P., O'Neill C.A., Halliwell B., and Cross C.E. Tyrosine modification by reactive nitrogen species: A closer look. Arch. Biochem. Biophys. 319 (1995) 341-349
141. Van Der Vliet A., Smith D., O'Neill C.A., Kaur H., Darley-Usmar V., Cross C.E., and Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion. Biochem. J. 303 (1994) 295-301
142. Van Poppel G., Spanhaak S., and Ockhuizen T. Effect of β-carotene on immunological indexes in healthy male smokers. Am. J. Clin. Nutr. 57 (1993) 402-407
143. Vissers M.C.M., and Winterbourn C.C. Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem. J. 307 (1995) 57-62
144. Warner R.L., Paine R., Christensen P.J., Marletta M.A., Richards M.K., Wilcoxen S.E., and Ward P.A. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 12 (1995) 649-661
145. White A.C., Thannickal V.J., and Fanburg B.L. Glutathione deficiency in human disease. J. Nutr. Biochem. 5 (1994) 218-226
146. Widdicombe J.H. Accumulation of airway mucus in cystic fibrosis. Pulm. Pharmacol. 7 (1994) 225-233
147. Winklhofer-Roob B.M. Oxygen free radicals and antioxidants in cystic fibrosis: The concept of an oxidant-antioxidant imbalance. Acta Paediatr. Suppl. 395 (1994) 49-57
148. Winklhofer-Roob B.M., Ziouzenkova O., Puhl H., Ellemunter H., Greiner P., Müller G., Van'T Hof M.A., Esterbauer H., and Shmerling D.H. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: Improvement during vitamin E supplementation. Free Rad. Biol. Med. 19 (1995) 725-733
149. Witko-Sarsat V., Delacourt C., Rabier D., Bardet J., Nguyen A.T., and Descamps-Latscha B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 152 (1995) 1910-1916
150. Wizemann T.M., Gardner C.R., Laskin J.D., Quinones S., Durham S.K., Goller N.L., Ohnishi S.T., and Laskin D.L. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukocyte Biol. 56 (1994) 759-768
151. Wolz C., Hohloch K., Ocaktan A., Poole K., Evans R.W., Rochel N., Albrecht-Gary A.-M., Abdallah M.A., and Doring G. Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infect. Immun. (1994) 4021-4027
152. Zabner J., Couture L.A., Gregory R.J., Graham S.M., Smith A.E., and Welsh M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75 (1993) 207-216
153. Zachman R.D. Role of vitamin A in lung development. J. Nutr. 125 (1995) 1634S-1638S
154. Zapol W.M., Rimar S., Gillis N., Marletta M., and Bosken C.H. Nitric oxide and the lung. Am. J. Respir. Crit. Care Med. 149 (1994) 1375-1380
155. Zeiher B.G., Eichwald E., Zabner J., Smith J.J., Puga A.P., et al. A mouse model for the AFSO8 allele of cystic fibrosis. J. Clin. Invest. 96 (1995) 2051-2064